Anna Garbelli

1.1k total citations
24 papers, 799 citations indexed

About

Anna Garbelli is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Anna Garbelli has authored 24 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Infectious Diseases and 8 papers in Virology. Recurrent topics in Anna Garbelli's work include HIV Research and Treatment (8 papers), RNA and protein synthesis mechanisms (8 papers) and HIV/AIDS drug development and treatment (7 papers). Anna Garbelli is often cited by papers focused on HIV Research and Treatment (8 papers), RNA and protein synthesis mechanisms (8 papers) and HIV/AIDS drug development and treatment (7 papers). Anna Garbelli collaborates with scholars based in Italy, United States and Belgium. Anna Garbelli's co-authors include Giovanni Maga, Maurizio Botta, Fabrizio Manetti, Federico Falchi, Annalaura Brai, Ursula Dietrich, Lorenzo Botta, Marco Radi, Valentina Riva and Cristina Tintori and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and PLoS ONE.

In The Last Decade

Anna Garbelli

23 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Garbelli Italy 15 505 137 102 100 92 24 799
János András Mótyán Hungary 12 338 0.7× 165 1.2× 44 0.4× 60 0.6× 59 0.6× 45 648
Giada A. Locatelli Italy 14 398 0.8× 136 1.0× 82 0.8× 194 1.9× 20 0.2× 17 770
Zhenlong Liu China 15 326 0.6× 220 1.6× 302 3.0× 45 0.5× 307 3.3× 48 854
Tsuyoshi Adachi Japan 12 370 0.7× 305 2.2× 94 0.9× 177 1.8× 46 0.5× 20 1.2k
You Yu China 12 358 0.7× 122 0.9× 127 1.2× 34 0.3× 89 1.0× 21 578
Sabrina Auerochs Germany 19 450 0.9× 136 1.0× 130 1.3× 102 1.0× 160 1.7× 21 1.2k
G. Renuka Kumar United States 16 394 0.8× 165 1.2× 21 0.2× 28 0.3× 67 0.7× 22 771
Dongrong Yi China 12 210 0.4× 188 1.4× 28 0.3× 41 0.4× 128 1.4× 33 512
Binay Chaubey India 14 367 0.7× 57 0.4× 72 0.7× 21 0.2× 36 0.4× 24 557
Laurent Bonnac United States 14 279 0.6× 160 1.2× 46 0.5× 112 1.1× 37 0.4× 30 518

Countries citing papers authored by Anna Garbelli

Since Specialization
Citations

This map shows the geographic impact of Anna Garbelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Garbelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Garbelli more than expected).

Fields of papers citing papers by Anna Garbelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Garbelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Garbelli. The network helps show where Anna Garbelli may publish in the future.

Co-authorship network of co-authors of Anna Garbelli

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Garbelli. A scholar is included among the top collaborators of Anna Garbelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Garbelli. Anna Garbelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bonanomi, Marcella, Anna Garbelli, Anna Cleta Croce, et al.. (2025). Tracking micro- and nanoplastics in Aedes albopictus: From ingestion to metabolic disruption. The Science of The Total Environment. 1002. 180447–180447.
2.
Secchi, Massimiliano, Anna Garbelli, Valentina Riva, et al.. (2024). Synergistic action of human RNaseH2 and the RNA helicase-nuclease DDX3X in processing R-loops. Nucleic Acids Research. 52(19). 11641–11658. 3 indexed citations
3.
Croce, Anna Cleta, et al.. (2023). Developmental and Nutritional Dynamics of Malpighian Tubule Autofluorescence in the Asian Tiger Mosquito Aedes albopictus. International Journal of Molecular Sciences. 25(1). 245–245. 2 indexed citations
4.
Secchi, Massimiliano, et al.. (2022). DEAD-Box RNA Helicases DDX3X and DDX5 as Oncogenes or Oncosuppressors: A Network Perspective. Cancers. 14(15). 3820–3820. 16 indexed citations
5.
Galli, Silvia, Anna Garbelli, Silvia Bione, et al.. (2021). A Role for Human DNA Polymerase λ in Alternative Lengthening of Telomeres. International Journal of Molecular Sciences. 22(5). 2365–2365. 3 indexed citations
6.
Brai, Annalaura, Adele Boccuto, Martina Monti, et al.. (2020). Exploring the Implication of DDX3X in DENV Infection: Discovery of the First-in-Class DDX3X Fluorescent Inhibitor. ACS Medicinal Chemistry Letters. 11(5). 956–962. 18 indexed citations
7.
Riva, Valentina, Anna Garbelli, Annalaura Brai, et al.. (2020). Unique Domain for a Unique Target: Selective Inhibitors of Host Cell DDX3X to Fight Emerging Viruses. Journal of Medicinal Chemistry. 63(17). 9876–9887. 9 indexed citations
8.
Brai, Annalaura, Valentina Riva, Francesco Saladini, et al.. (2020). DDX3X inhibitors, an effective way to overcome HIV-1 resistance targeting host proteins. European Journal of Medicinal Chemistry. 200. 112319–112319. 27 indexed citations
9.
Riva, Valentina, Anna Garbelli, Federica Casiraghi, et al.. (2020). Novel alternative ribonucleotide excision repair pathways in human cells by DDX3X and specialized DNA polymerases. Nucleic Acids Research. 48(20). 11551–11565. 10 indexed citations
10.
Riva, Valentina, et al.. (2020). Novel Insights into the Biochemical Mechanism of CK1ε and its Functional Interplay with DDX3X. International Journal of Molecular Sciences. 21(17). 6449–6449. 1 indexed citations
11.
Brai, Annalaura, Cristina Tintori, Claudio Zamperini, et al.. (2016). Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents. Proceedings of the National Academy of Sciences. 113(19). 5388–5393. 83 indexed citations
12.
Tintori, Cristina, Annalaura Brai, Lorenzo Botta, et al.. (2015). Homology Model-Based Virtual Screening for the Identification of Human Helicase DDX3 Inhibitors. Journal of Chemical Information and Modeling. 55(11). 2443–2454. 81 indexed citations
13.
Samuele, Alberta, et al.. (2013). The Power of Enzyme Kinetics in the Drug Development Process. Current Pharmaceutical Biotechnology. 14(5). 551–560. 3 indexed citations
14.
Radi, Marco, Federico Falchi, Anna Garbelli, et al.. (2012). Discovery of the first small molecule inhibitor of human DDX3 specifically designed to target the RNA binding site: Towards the next generation HIV-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(5). 2094–2098. 72 indexed citations
15.
Garbelli, Anna, Marco Radi, Federico Falchi, et al.. (2011). Targeting the Human DEAD-Box Polypeptide 3 (DDX3) RNA Helicase as a Novel Strategy to Inhibit Viral Replication. Current Medicinal Chemistry. 18(20). 3015–3027. 48 indexed citations
18.
Dundon, William G., Anna Garbelli, Bianca Zecchin, et al.. (2011). The PDZ-Ligand and Src-Homology Type 3 Domains of Epidemic Avian Influenza Virus NS1 Protein Modulate Human Src Kinase Activity during Viral Infection. PLoS ONE. 6(11). e27789–e27789. 14 indexed citations
19.
Crespan, Emmanuele, et al.. (2011). Exploiting the Nucleotide Substrate Specificity of Repair DNA Polymerases To Develop Novel Anticancer Agents. Molecules. 16(9). 7994–8019. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026